[1]
;
Hernández Buitrado, Stephanie
[1]
;
Camacho, Francisco
[1]
;
Meneses-Gaviria, Sandra Viviana
[1]
Colombia
El síndrome de Sneddon-Wilkinson es una dermatosis neutrofílica crónica con prevalencia desconocida mundialmente y sin una patogenia clara. El tratamiento establecido como primera línea es la dapsona. El propósito de este reporte es exponer el caso de una paciente tratada con colchicina como primera línea debido a la seguridad y eficacia, con un resultado exitoso.
The subcorneal pustular dermatosis, also known as Sneddon-Wilkinson disease, is a rare, benign, although recurrent condition classified within the group of neutrophilic dermatoses. Its pathogenesis remains unclear. Clinically, pustules appear on the trunk and intertriginous areas, rarely on acral locations. Histologically, subcorneal collections of neutrophils form pustules. While dapsone remains the treatment of choice, this case report highlights a successful alternative treatment using colchicine, a well-established second-line drug, although multiple treatments have been described today, among the most recent, for example, adalimumab, a monoclonal antibody against tumor necrosis factor α (TNF-α). Colchicine is accessible, safe, and effective, and should be considered among the first lines of treatment.
© 2001-2026 Fundación Dialnet · Todos los derechos reservados